Orphan G protein-coupled receptors: Targets for new therapeutic interventions

Annals of Medicine

Volumn 36, Issue 3, 2004, Pages 204-214

  Lin, Steven H S ^a   Civelli, Olivier ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug discovery; Ligand; Orphan receptor; Peptides; Prolactin releasing peptide

Indexed keywords

ADENINE; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GHRELIN; HORMONE RECEPTOR; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR; NEUROMEDIN U; NEUROPEPTIDE Y RECEPTOR; NEUROTRANSMITTER; NOCICEPTIN; OREXIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; PROLACTIN; PROLACTIN RELEASING FACTOR; PROLACTIN RELEASING FACTOR RECEPTOR; SEROTONIN 1A RECEPTOR; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; UROTENSIN II;

ABSENCE; AMYGDALOID NUCLEUS; BRAIN NUCLEUS; BRAIN REGION; CELL COMMUNICATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; FOOD INTAKE; GENE FUNCTION; HUMAN; IN VIVO STUDY; NONHUMAN; PETIT MAL; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REGULATORY MECHANISM; SHORT SURVEY; SLEEP; SLEEP DISORDER; SPIKE WAVE; STRIA TERMINALIS; THALAMUS NUCLEUS;

ANIMALS; CENTRAL NERVOUS SYSTEM; DRUG THERAPY; EPILEPSY, ABSENCE; HUMANS; HYPOTHALAMIC HORMONES; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; SLEEP;

EID: 2542440005     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310024668     Document Type: Short Survey

References (59)

1. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 2003;100:4903-8.
2. Drews J. Drug discovery: a historical perspective. Science 2000;287:1960-4.
3. Civelli O, Nothacker HP, Saito Y, Wang Z, Lin SH, Reinscheid RK. Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors. Trends Neurosci 2001; 24:230-7.
4. Kawauchi H, Kawazoe I, Tsubokawa M, Kishida M, Baker BI. Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature 1983;305:321-3.
5. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996;380:243-7.
6. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998;396:670-674.
7. Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, Hervieu G, et al. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 1999;400:261-5.
8. Saito Y, Nothacker HP, Wang Z, Lin SH, Leslie F, Civelli O. Molecular characterization of the melanin-concentrating-hormone receptor. Nature 1999;400:265-9.
9. Lembo PM, Grazzini E, Cao J, Hubatsch DA, Pelletier M, Hoffert C, et al. The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat Cell Biol 1999;1:267-71.
10. Shimomura Y, Mori M, Sugo T, Ishibashi Y, Abe M, Kurokawa T, et al. Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem Biophys Res Commun 1999;261:622-6.
11. Bachner D, Kreienkamp H, Weise C, Buck F, Richter D. Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett 1999;457:522-4.
12. Takekawa S, Asami A, Ishihara Y, Terauchi J, Kato K, Shimomura Y, et al. T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur J Pharmacol 2002;438:129-35.
13. Borowsky B, Durkin MM, Ogozalek K, Marzabadi MR, DeLeon J, Lagu B, et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 2002;8:825-30.
14. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, et al. A prolactin-releasing peptide in the brain. Nature 1998;393:272-6.
15. Welch SK, O'Hara BF, Kilduff TS, Heller HC. Sequence and tissue distribution of a candidate G-coupled receptor cloned from rat hypothalamus. Biochem Biophys Res Commun 1995;209:606-13.
16. Marchese A, Heiber M, Nguyen T, Heng HH, Saldivia VR, Cheng R, et al. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostarin receptors. Genomics 1995;29:335-44.
17. Chen C, Dun SL, Dun JH, Chang JK. Prolactin-releasing peptide-immunoreactivity in A1 and A2 noradrenergic neurons of the rat medulla. Brain Res 1999;822:276-9.
18. Jarry H, Heuer H, Schomburg L, Bauer K2000Prolactin-releasing pepticles do not stimulate prolactin release in vivo. Neuroendocrinology 71:62-7.
19. Morales T, Hinuma S, Sawchenko PE. Prolactin-releasing peptide is expressed in afferents to the endocrine hypothalamus, but not in neurosecretory neurones. J Neuroendocrinology 2000;12:131-40.
20. Maruyama M, Marsumoro H, Fujiwara K, Kitada C, Hinuma S, Onda H, et al. Immunocytochemical localization of Prolactin-Releasing Peptide in the Rat Brain. Endocrinology 1999;140:2326-33.
21. Seale AP, Itoh T, Moriyama S, Takahashi A, Kawauchi H, Sakamoto T, et al. Isolation and characterization of a homologue of mammalian prolactin-releasing peptide from the tilapia brain and its effect on prolactin release from the tilapia pituitary. Gen Comp Endocrinol 2002;125:328-39.
22. Moriyama S, Iro T, Takahashi A, Amano M, Sower SA, Hirano T, et al. A homolog of mammalian PRL-releasing peptide (fish arginyl-phenylalanyl-amide peptide) is a major hypothalamic pepride of PRL release in teleost fish. Endocrinology 2002;143:2071-9.
23. Sakamoto T, Fujimoto M, Andot M. Fishy tales of prolactin-releasing peptide. Int Rev Cytol 2003;225:91-130.
24. Samson WK, Resch ZT, Murphy TC, Chang JK. Gender-biased activity of the novel prolacrin releasing peptides: comparison with thyrotropin releasing hormone reveals only pharmacologic effects. Endocrine 1998;9:289-91.
25. Watanobe H, Schioth HB, Wikberg JE, Suda T. Evaluation of the role for prolactin-releasing peptide in prolactin secretion induced by ether stress and suckling in the rat: comparison with vaso active intestinal peptide. Brain Res 2000;865:91-6.
26. Yuan ZF, Yang SC, Pan JT. Effects of prolactin-releasing peptide on tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in estrogen-treated female rats. J Biomed Sci 2002;9:112-8.
27. Anderson ST, Kokay IC, Lang T, Grattan DR, Curlewis JD. Quantification of prolactin-releasing peptide (PrRP) mRNA expression in specific brain regions of the rat during the oestrous cycle and in lactation. Brain Res 2003;973:64-73.
28. Skinner DC, Caraty A. Prolacrin release during the estradiol-induced LH surge in ewes: modulation by progesterone but no evidence for prolactin-releasing peptide involvement. J Endocrinol 2003;177:453-60.
29. Kataoka Y, Iijima N, Yano T, Kakihara K, Hayashi S, Hinuma S, et al. Gonadal regulation of PrRP mRNA expression in the nucleus tractus solitarius and ventral and lateral reticular nuclei of the rat. Brain Res Mol Brain Res 2001;87:42-7.
30. Tokita R, Nakata T, Katsumata H, Konishi S, Onodera H, Imaki J, et al. Prolactin secretion in response to prolactin-releasing peptide and the expression of the prolactin-releasing peptide gene in the medulla oblongata are estrogen dependent in rats. Neurosci Lett 1999;276:103-6.
31. Matsumoto H, Noguchi J, Horikoshi Y, Kawamata Y, Kitada C, Hinuma S, et al. Stimulation of prolactin release by prolactin-releasing peptide in rats. Biochem Biophys Res Commun 1999;259:321-4.
32. Kawamata Y, Fujii R, Fukusumi S, Habata Y, Hosoya M, Hinuma S, et al. Analyses for susceptibility of rat anterior pituitary cells to prolactin-releasing peptide. Endocrine 2000; 12:235-21.
33. Roland BL, Sutton SW, Wilson SJ, Luo L, Pyati J, Huvar R, et al. Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery. Endocrinology 1999;140: 5736-45.
34. Matsumoto H, Maruyama M, Noguchi J, Horikoshi Y, Fujiwara K, Kitada C, et al. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolacrin-releasing pepride in rats. Neurosci Lett 2000;285:234-8.
35. Seal LJ, Small CJ, Dhillo WS, Kennedy AR, Ghatei MA, Bloom SR. Prolactin-releasing peptide releases corricotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus. Neuroendocrinology 2002;76:70-8.
36. Samson WK, Keown C, Samson CK, Samson HW, Lane B, Baker JR, et al. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion. Endocrine 2003; 20:59-66.
37. Lin SH, Leslie FM, Civelli O. Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception. Brain Res 2002;952:15-30.
38. Zhu LL, Onaka T. Facilitative role of prolactin-releasing peptide neurons in oxytocin cell activation after conditioned-fear stimuli. Neuroscience 2003;118:1045-53.
39. Iijima N, Matsumoto Y, Yano T, Tanaka M, Yamamoto T, Kakihara K, et al. A novel function of prolactin-releasing peptide in the control of growth hormone via secretion of somatostatin from the hypothalamus. Endocrinology 2001; 142:3239-43.
40. Samson WK, Resch ZT, Murphy TC. A novel action of the newly described prolactin-releasing peptides: cardiovascular regulation. Brain Res 2000;858:19-25.
41. Horiuchi J, Saigusa T, Sugiyama N, Kanba S, Nishida Y, Sato Y, et al. Effects of prolacrin-releasing peptide microinjection into the ventrolateral medulla on arterial pressure and sympathetic activity in rats. Brain Res 2002;958:201-9.
42. Lawrence CB, Celsi F, Brennand J, Luckman SM. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat Neurosci 2000;7:645-6.
43. Lawrence CB, Ellacott KL, Luckman SM. PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology 2002;143:360-7.
44. Ellacott KL, Lawrence CB, Rothwell NJ, Luckman SM. PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Endocrinology 2002;143:368-74.
45. Lin SH, Arai AC, Espana RA, Berridge CW, Leslie FM, Huguenard JR, et al. Prolactin-releasing peptide (PrRP) promotes awakening and suppresses absence seizures. Neuroscience 2002;114:229-38.
46. Cox CL, Huguenard JR, Prince DA. Peptidergic modulation of intrathalamic circuit activity in vitro: actions of cholecystokinin. J Neurosci 1997;17:70-82.
47. Marescaux C, Vergnes M, Depaulis A. Genetic absence epilepsy in rats from Strasbourg-a review. J Neural Transm Suppl 1992;35:37-69.
48. Kimura A, Ohmichi M, Tasaka K, Kanda Y, Ikegami H, Hayakawa J, et al. Prolactin-releasing peptide activation of the prolactin promoter is differentially mediated by extracellular signal-regulated protein kinase and c-Jun N-terminal protein kinase. J Biol Chem 2000;275(5)3667-74.
49. Craven SE, Bredt DS. PDZ proteins organize synaptic signaling pathways. Cell 1998;83:495-8.
50. Dong H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 1997;386:279-84.
51. Lin SH, Arai AC, Wang Z, Nothacker HP, Civelli O. The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5 methylisoxazole-4-propionic acid receptor clustering. Mol Pharmacol 2001;60:916-23.
52. Hall RA, Premont RT, Chow CW, Blitzer JT, Pitcher JA, Claing A, et al. The β2- adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 1998;392:626-30.
53. Matsuda S, Mikawa S, Hirai H. Phosphorylation of serine-880 in GluR2 by protein kinase C prevents its C terminus from binding with glutamate receptor-interacting protein. J Neurochem 1999;73:1765-8.
54. Chung HJ, Xia J, Scannevin RH, Zhang X, Huganir RL. Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. J Neurosci 2000;20:7258-67.
55. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 1995;270:792-4.
56. Jenck F, Moreau JL, Martin JR, Kilpatrick GJ, Reinscheid RK, Monsma FJ Jr, et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA 1997;94:14854-8.
57. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and Orexin receptors: A family of hypothalamic neuropeptides and G-protein coupled receptors that regulate feeding behavior. Cell 1998;92:573-85.
58. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, et al. Human urotensin-II is a potent vaso-constrictor and agonist for the orphan receptor GPR14. Nature 1999;401:282-6.
59. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001; 411:613-7.